We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRH:NYSECRH PLC Analysis

Data as of 2026-05-25 - not real-time

$100.37

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

CRH’s stock is trading at $100.37, well below its 20‑day ($109.57) and 50‑day ($109.42) moving averages, and the RSI of 34 signals oversold conditions. Technical indicators such as a bearish MACD and a price hovering just above the $97.80 support level suggest short‑term downside pressure. Meanwhile, the company delivered a 9% year‑over‑year revenue growth in Q1, reaching $7.4 billion, and posted a healthy profit margin of 9.6% despite an operating margin that is near breakeven. The balance sheet is heavily leveraged with $20.4 billion of debt versus $3.24 billion of cash, yielding a debt‑to‑equity ratio of over 80, but cash flow remains solid (operating cash flow $5.67 billion). Valuation metrics show a forward PE of 15 and a target median price of $143.5, implying roughly 42% upside potential. Dividend sustainability looks reasonable given a low payout ratio of 28% and steady cash generation, while the “Extreme Greed” sentiment in the fear‑greed index reflects strong investor appetite for the stock.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages and near support
  • Bearish MACD and low RSI indicating short‑term weakness
  • Increasing volume suggests potential for a bounce

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong Q1 revenue growth and solid profit margins
  • Target price upside of ~42% and forward PE compression
  • Infrastructure spending tailwinds, especially in water projects

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Diversified geographic exposure with U.S. driving 75% of profit
  • Sustainable dividend backed by low payout ratio
  • Long‑term demand for building materials and infrastructure renewal

Key Metrics & Analysis

Financial Health

Revenue Growth9.10%
Profit Margin9.64%
P/E Ratio18.6
ROE15.81%
ROA6.05%
Debt/Equity83.23
P/B Ratio2.9
Op. Cash Flow$5.7B
Free Cash Flow$786.1M

Technical Analysis

TrendNeutral
RSI34.2
Support$97.80
Resistance$119.27
MA 20$109.57
MA 50$109.42
MA 200$115.95
MACDBearish
VolumeIncreasing
Fear & Greed Index91.8

Valuation

Target Price$142.66
Upside/Downside42.13%
GradeUndervalued
TypeBlend
Dividend Yield1.55%

Risk Assessment

Beta1.41
Volatility32.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.